Streamline Net Debt vs Other Current Liab Analysis
STRM Stock | USD 3.12 0.03 0.95% |
Streamline Health financial indicator trend analysis is much more than just breaking down Streamline Health prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Streamline Health is a good investment. Please check the relationship between Streamline Health Net Debt and its Other Current Liab accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Net Debt vs Other Current Liab
Net Debt vs Other Current Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Streamline Health Net Debt account and Other Current Liab. At this time, the significance of the direction appears to have very week relationship.
The correlation between Streamline Health's Net Debt and Other Current Liab is 0.22. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Streamline Health Solutions, assuming nothing else is changed. The correlation between historical values of Streamline Health's Net Debt and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Streamline Health Solutions are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Net Debt i.e., Streamline Health's Net Debt and Other Current Liab go up and down completely randomly.
Correlation Coefficient | 0.22 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Other Current Liab
Most indicators from Streamline Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Streamline Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. As of the 26th of November 2024, Sales General And Administrative To Revenue is likely to grow to 0.47, while Selling General Administrative is likely to drop about 8.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 17.4M | 24.9M | 22.6M | 19.1M | Depreciation And Amortization | 3.6M | 4.9M | 4.9M | 2.9M |
Streamline Health fundamental ratios Correlations
Click cells to compare fundamentals
Streamline Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Streamline Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 31.7M | 26.0M | 61.8M | 61.5M | 41.7M | 32.0M | |
Short Long Term Debt Total | 3.8M | 2.7M | 10.1M | 9.7M | 10.6M | 6.0M | |
Other Current Liab | 2.5M | 1.5M | 6.0M | 6.7M | 3.6M | 2.8M | |
Total Current Liabilities | 15.6M | 7.4M | 13.5M | 16.8M | 13.7M | 10.2M | |
Total Stockholder Equity | 16.0M | 17.5M | 34.0M | 35.5M | 18.8M | 15.7M | |
Property Plant And Equipment Net | 152K | 495K | 341K | 111K | 88K | 83.6K | |
Net Debt | 2.2M | 312K | 256K | 3.2M | 7.4M | 7.7M | |
Retained Earnings | (79.4M) | (79.1M) | (85.7M) | (97.0M) | (115.7M) | (109.9M) | |
Accounts Payable | 1.3M | 272K | 778K | 626K | 1.3M | 1.1M | |
Non Current Assets Total | 25.1M | 18.7M | 46.7M | 45.5M | 32.9M | 19.4M | |
Non Currrent Assets Other | 695K | 886K | 948K | 1.7M | 1.7M | 1.2M | |
Net Receivables | 4.0M | 3.1M | 4.7M | 8.7M | 5.0M | 5.1M | |
Common Stock Shares Outstanding | 22.7M | 30.2M | 42.8M | 49.3M | 3.8M | 3.6M | |
Liabilities And Stockholders Equity | 31.7M | 26.0M | 61.8M | 61.5M | 41.7M | 32.0M | |
Non Current Liabilities Total | 55K | 1.1M | 14.3M | 9.2M | 9.2M | 6.8M | |
Other Current Assets | 919K | 1.8M | 568K | 710K | 629K | 1.2M | |
Other Stockholder Equity | 95.1M | 96.3M | 119.2M | 132.0M | 133.9M | 140.6M | |
Total Liab | 15.6M | 8.5M | 27.8M | 26.0M | 22.9M | 16.6M | |
Total Current Assets | 6.6M | 7.3M | 15.1M | 16.0M | 8.8M | 12.7M | |
Short Term Debt | 3.8M | 1.7M | 454K | 785K | 1.5M | 1.2M | |
Cash | 1.6M | 2.4M | 9.9M | 6.6M | 3.2M | 5.6M | |
Cash And Short Term Investments | 1.6M | 2.4M | 9.9M | 6.6M | 3.2M | 5.6M | |
Property Plant And Equipment Gross | 152K | 495K | 341K | 357K | 379K | 360.1K | |
Other Liab | 55K | 130K | 4.6M | 271K | 311.7K | 296.1K | |
Other Assets | 695K | 886K | 948K | 1.7M | 1.5M | 1.0M | |
Common Stock Total Equity | 208K | 305K | 316K | 576K | 662.4K | 695.5K | |
Common Stock | 305K | 316K | 478K | 576K | 590K | 619.5K | |
Property Plant Equipment | 152K | 104K | 341K | 5.9M | 6.8M | 7.2M | |
Current Deferred Revenue | 8.0M | 3.9M | 5.8M | 8.4M | 7.1M | 6.8M | |
Intangible Assets | 8.7M | 6.6M | 22.3M | 20.6M | 17.9M | 13.0M | |
Inventory | 1.3M | 901K | 1.4M | 1.0 | 0.9 | 0.86 | |
Net Tangible Assets | (8.2M) | 208K | (11.4M) | (2.4M) | (2.7M) | (2.9M) | |
Retained Earnings Total Equity | (76.6M) | (79.4M) | (79.1M) | (97.0M) | (87.3M) | (91.7M) | |
Long Term Debt Total | 3.9M | 3.4M | 989K | 9.0M | 8.1M | 5.4M | |
Capital Surpluse | 82.5M | 95.1M | 96.3M | 132.0M | 151.8M | 89.1M | |
Deferred Long Term Liab | 55K | 130K | 806K | 167K | 150.3K | 142.8K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (4.80) | Revenue Per Share 5.249 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.